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Corin is a protease that activates atrial natriuretic peptide, a
cardiac hormone important in the control of blood pressure
and salt–water balance. Here we examined the role of corin in
regulating blood pressure and sodium homeostasis upon
dietary salt challenge. Radiotelemetry-tracked blood pressure
in corin knockout mice on a high-salt diet (4% sodium
chloride) was significantly increased; however, there was no
such change in similarly treated wild-type mice. In the
knockout mice on the high-salt diet there was an impairment
of urinary sodium excretion and an increase in body weight,
but no elevation of plasma renin or serum aldosterone levels.
When the knockout mice on the high-salt diet were treated
with amiloride, an epithelial sodium channel blocker that
inhibits renal sodium reabsorption, the impaired urinary
sodium excretion and increased body weight were
normalized. Amiloride treatment also reduced high blood
pressure caused by the high-salt diet in these mice. Thus, the
lack of corin in mice impairs their adaptive renal response to
high dietary salt, suggesting that corin deficiency may
represent an important mechanism underlying salt-sensitive
hypertension.
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Hypertension is a major cardiovascular disease. Excessive
dietary salt has long been considered a risk factor in
hypertension.1 Approximately 50% of essential hypertension
cases are salt sensitive, but the underlying mechanisms are
poorly understood.2,3 Atrial natriuretic peptide (ANP)
regulates blood pressure and salt–water balance.4 In mice,
plasma ANP levels were elevated upon high-salt diets,5 and
deficiency in ANP or its receptor causes hypertension.6,7 To
date, however, it is unclear whether a defective ANP pathway
alters the response of blood pressure to dietary salts. In ANP-
deficient mice, salt-sensitive hypertension was observed
initially6 but not confirmed in a later study.8 In ANP
receptor knockout mice, elevated blood pressure was un-
changed upon dietary salt loading in an early study7 but
appeared to be increased in later studies.9,10 The reasons for
the apparent differences may be due to different experimental
protocols (conscious vs. anesthetized conditions)11 and
methods for measuring blood pressure, which are notoriously
challenging if tail-cuff methods are used.
Corin is a cardiac membrane serine protease.12,13 It
promotes the natriuretic system by activating ANP.14,15 In
mice, corin deficiency prevents pro-ANP to ANP conversion,
causing hypertension and cardiac hypertrophy.16,17 Corin
deficiency may also contribute to hypertensive disease in
humans. In African Americans, single-nucleotide poly-
morphisms that impaired corin function were found in
patients with hypertension, cardiac hypertrophy, and heart
failure.18–21 Recent studies detected soluble corin in human
plasma22–25 and showed that plasma corin levels were reduced
in patients with heart failure.22,26
In a previous study, hypertension in corin knockout
(Cor/) mice was exacerbated upon an 8% NaCl diet
challenge.16 The same treatment, however, also elevated
blood pressure in control wild-type (WT) mice. It is difficult,
therefore, to conclude whether corin deficiency altered the
response of blood pressure to dietary salts. In this study, we
examined the effect of 2 and 4% high-salt diets on blood
pressure in Cor/ mice and investigated the possible
mechanisms underlying hypertension in these mice. Our
data indicated that corin deficiency impaired renal sodium
excretion upon dietary salt challenges, which contributed to
salt-sensitive hypertension in these mice.
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RESULTS
Salt-sensitive hypertension in Cor/ mice
We examined the effect of high-salt diets on blood pressure in
Cor/ and WT mice. No significant changes were detected
when Cor/ or WT mice were treated with a medium–high-
salt (2% NaCl) diet for 3 weeks (data not shown). After 1 week
on a higher-salt (4% NaCl) diet, systolic blood pressure
increased in Cor/ mice (from 125.7±3.2 to 133±2.9 mm
Hg, Po0.01; Figure 1a). Similar increases in diastolic blood
pressure and mean arterial blood pressure were also observed
(data not shown). In contrast, no significant increase in blood
pressure was observed in similarly treated WT mice (Figure
1a). After 3 weeks on 4% NaCl salt diet, Cor/ mice were
switched to a normal-salt (0.3% NaCl) diet, and their blood
pressure remained high for 2 more weeks (Figure 1a). When
net changes in systolic blood pressure were examined, the effect
was significantly greater in Cor/ mice than in WT controls
(Figure 1b), indicating that blood pressure was more sensitive
to dietary salt loading in Cor/ than WT mice.
Metabolic and electrolyte analyses
To understand the mechanism underlying the observed salt-
sensitive hypertension in Cor/ mice, we conducted meta-
bolic studies in WT and Cor/ mice. Similar food and water
intakes were found with the normal-salt diet (Figure 2a). On
the high-salt diet, food intakes remained unchanged, but water
intakes and urine volumes increased similarly in WT and
Cor/ mice during the first week and remained at high levels
in weeks 2 and 3. Levels of plasma Naþ , Cl, and Kþ were
unchanged in these mice on the high-salt diet (Figure 2b).
Apparently, plasma electrolyte balance was maintained by
increased urinary Naþ /Cl excretion (Figure 2c). Compared
with WT mice, however, Cor/ mice had reduced Naþ /Cl
excretion during the first week of high-salt diet. The difference
in Naþ /Cl excretion between WT and Cor/ mice narrowed
in the following weeks (Figure 2c), indicating that a steady
state of salt–water balance was reached gradually in Cor/
mice. In contrast, levels of urinary Kþ excretion were similar
in Cor/ and WT mice (Figure 2c).
In Cor/ mice on the high-salt diet, the impaired urinary
Naþ /Cl excretion was accompanied by increased body
weight compared with that in WT mice (Figure 3a). Such a
difference in body weight gain between WT and Cor/ mice
was not observed on the normal-salt diet (Figure 3b).
Levels of plasma renin and serum aldosterone
To examine whether an enhanced renin–angiotensin (Ang)
–aldosterone system (RAAS) may be responsible for hyper-
tension and sodium–water retention in Cor/ mice, we
measured plasma renin concentration and serum aldoster-
one. Similar plasma renin levels were found in WT and
Cor/ mice on the normal-salt diet (Figure 4a). On the
high-salt diet, both groups had significantly lower plasma
renin concentration, indicating that renin levels were
suppressed. There was no significant difference in plasma
renin concentration between the two groups (Figure 4a).
Serum aldosterone levels were found to be lower in Cor/
than in WT mice on both the normal- and high-salt diets
(Figure 4b). The results indicated that an enhanced RAAS
was unlikely to be present in Cor/ mice.
Losartan treatment
To further examine the potential role of RAAS, we treated
Cor/ mice with losartan, an Ang II type 1 receptor blocker.
Losartan reduced blood pressure in WT and Cor/ mice on
both the normal- and high-salt diets (Figure 5a and c). The
extent of reduction was similar in both groups (Figure 5b and
d). The treatment did not lower blood pressure in Cor/
mice to similar levels in WT mice. The results supported that
mechanisms other than an enhanced RAAS were likely
involved in hypertension in Cor/ mice.
Amiloride treatment
Epithelial sodium channel (ENaC) mediates renal Naþ
reabsorption, thereby reducing Naþ excretion.27,28 A recent
report showed that the corin/ANP pathway may regulate
renal ENaC expression and/or activity.29 To determine
whether the impaired urinary Naþ excretion in Cor/ mice
on high-salt diets was due to an enhanced ENaC activity, we
tested the hypothesis that amiloride, an ENaC blocker, might
increase urinary Naþ excretion and decrease body weight
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Figure 1 | Salt-sensitive hypertension in corin knockout
(Cor/) mice. (a) Cor/ and wild-type (WT) mice on a 0.3% NaCl
diet (basal) were switched to a 4% NaCl diet for 3 weeks (w) and
back to the 0.3% NaCl diet for 3 w. Blood pressure was measured
by radiotelemetry. Systolic blood pressure (SBP) in Cor/ and WT
mice is shown. n¼ 6 mice per group. **Po0.01 vs. WT mice of the
same group; wPo0.01 vs. Cor/ mice of the basal group by two-
way analysis of variance (ANOVA). (b) Changes in SBP from the
basal group of the same genotype were calculated. n¼ 6 mice per
group. *Po0.05 vs. WT mice of the same group by two-way
ANOVA.
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gain in Cor/ mice. No significant changes in urinary
Naþ excretion were observed in WT and Cor/ mice on
normal-salt diet upon amiloride treatment. The treatment,
however, corrected impaired Naþ excretion in Cor/ mice
on the high-salt diet (Figure 6a). Consistently, Cor/ mice
on the high-salt diet and treated with amiloride had body
weight gains comparable to those in WT mice (Figure 6b).
We measured blood pressure in mice treated with
amiloride (Figure 7a). No significant changes in blood
pressure were observed in Cor/ mice on the normal-salt
diet after amiloride treatment. The treatment reduced
elevated blood pressure in Cor/ mice on the high-salt
diet. In WT mice on the normal- or high-salt diet, no
significant changes in blood pressure were observed after
amiloride treatment (Figure 7a). The net effect of amiloride
on systolic blood pressure was significantly greater in
Cor/ mice than in WT mice on the high-salt diet (Figure
7b), indicating that inhibiting ENaC activity increased
urinary Naþ excretion and ameliorated hypertension in
Cor/ mice.
Amlodipine treatment
To understand the mechanism underlying hypertension in
Cor/ mice on the normal-salt diet, we examined the effect
of amlodipine, a calcium channel blocker, on blood pressure.
Amlodipine reduced the blood pressure in Cor/ and WT
mice on the normal-salt diet (Figure 8a). The reduction was
greater in Cor/ than in WT mice when 1.5 mg/kg of
amlodipine was used (Figure 8b). Amlodipine also reduced
blood pressure in WT and Cor/ mice on the high-salt diet
(Figure 8c). However, the reduction was similar in both
groups (Figure 8d). Blood pressure in Cor/ mice remained
significantly higher than that in similarly treated WT mice
(Figure 8c).
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Figure 2 |Metabolic studies and reduced sodium excretion in corin knockout (Cor/) mice. (a) Food and water intake, urine
volume, (b) plasma electrolytes, and (c) urinary Naþ , Cl, and Kþ excretion were measured in wild-type (WT) and Cor/ mice on 0.3%
and 4% NaCl diets. *Po0.01 vs. WT on 0.3% NaCl diet; wPo0.01 vs. Cor/ on 0.3% NaCl diet; zPo0.01 vs. WT on 4% NaCl diet for 1
week (w); yPo0.05 vs. Cor/ on 4% NaCl diet for 1 w, by two-way analysis of variance; n¼ 8–16 mice per group. NS, not statistically
significant.
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Figure 3 | Increased body weight in corin knockout (Cor/)
mice on high-salt diet. Wild-type (WT) and Cor/ mice were on
(a) 4% NaCl or (b) 0.3% NaCl diets. Body weight changes up to 3
weeks (w) were examined. n¼ 5 mice per group. P values vs. WT
of the same group by two-way analysis of variance were shown.
d, day; NS, not statistically significant.
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DISCUSSION
In this study, we used radiotelemetry to monitor blood
pressure in Cor/ mice on normal- and high-salt diets. We
found that blood pressure in Cor/ mice was more sensitive
to dietary salts than that in WT mice, as indicated by the
exacerbated hypertension in Cor/ mice on the 4% NaCl
diet. We further investigated possible mechanisms underlying
the salt-sensitive hypertension in these mice. ANP is known
to antagonize the RAAS.30,31 Elevated plasma renin activities
were reported in ANP knockout mice on high-salt diets,
suggesting that hypertension in these mice may result from
an enhanced RAAS.11 This hypothesis, however, was not
supported by another study, which showed similar plasma
Ang II levels and responses to dietary salts in ANP knockout
and WT mice.5 In our study, we did not detect elevated levels
of plasma renin or serum aldosterone in Cor/ mice (Figure
4a and b). Moreover, losartan did not normalize high blood
pressure in Cor/ mice (Figure 5a and c), indicating that an
enhanced RAAS is unlikely to be a key determinant for salt-
sensitive hypertension in Cor/ mice.
In the metabolic studies, no major differences were found
in food/water intakes, body weight, and plasma electrolyte
levels between Cor/ and WT mice on the normal-salt diet.
After 1 week of dietary salt challenge, Cor/ mice had levels
of plasma electrolytes similar to those in WT mice but
exhibited a significant reduction in urinary Naþ /Cl
excretion. This was accompanied by body weight gains,
indicating that water was retained to maintain electrolyte
homeostasis. Gradually, a steady state of renal sodium
excretion was reached in Cor/ mice, indicating that corin
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Figure 4 | Levels of plasma renin and serum aldosterone in
wild-type (WT) and corin knockout (Cor/) mice. Mice
were on 0.3 or 4% NaCl diets. (a) Plasma renin and (b) serum
aldosterone levels were measured, as described in the Materials
and Methods section. n¼ 7–8 mice per group. P values by two-
way analysis of variance were shown. Ang, angiotensin; NS, not
statistically significant.
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deficiency impaired an adaptive renal response to high
dietary salts, leading to salt-sensitive hypertension.
Corin is highly expressed in cardiomyocytes.32,33 Corin
mRNA and protein expression was found in the kidney,
including the proximal tubule, thick ascending limb,
connecting tubule, and collecting duct.13,29 In rat models of
proteinuric kidney disease, renal corin expression was
markedly reduced, and the reduction was associated with
sodium retention, indicating that corin defects may impair
sodium homeostasis in nephrotic syndrome.29,34 The result is
consistent with our findings of impaired sodium excretion
and exacerbated hypertension in Cor/ mice on high-salt
diets.
ENaC is essential for renal sodium reabsorption.27,28
Mutations in the ENaC genes cause hypertension in patients.2
Polzin et al.29 showed that renal b-ENaC expression was
increased in Cor/ mice, suggesting that corin may down-
regulate renal ENaC expression and activity.34 Zhao et al.35
also showed that ANP-mediated inhibition of sodium
reabsorption in distal nephron segments is critical for
promoting natriuresis. These data suggest that impaired
sodium excretion in Cor/ mice may be due to an increased
renal ENaC activity. Consistent with this hypothesis,
amiloride treatment prevented sodium retention, normalized
body weight gain (Figure 6), and reduced high blood pressure
(Figure 7) in Cor/ mice on high-salt diet. These results
support the hypothesis that renal corin expression has an
important role in regulating ENaC activity. Because corin is
the physiological pro-ANP convertase, it is likely that the
renal function of corin is mediated by its activation of ANP.
Interestingly, no significant changes in urinary sodium
excretion and blood pressure were observed when Cor/
mice on normal-salt diet were treated with amiloride (Figures
6a and 7a). Moreover, no significant differences in urinary
sodium excretion were detected between Cor/ and WT
mice on the normal-salt diet (Figure 2a), suggesting that
impaired sodium excretion may not be a major factor in
hypertension in Cor/ mice on normal-salt diet. ANP is
known to bind to its receptor on vascular smooth muscles to
promote intracellular cyclic guanosine monophosphate
production and vasodilation.4 Possibly, lack of corin reduced
ANP levels and increased vascular resistance in these mice,
contributing to hypertension on normal-salt diets. Consis-
tently, treatment of amlodipine, a calcium channel blocker
that relaxes vascular smooth muscles, reduced blood pressure
in Cor/ mice to a level similar to that in WT mice on the
normal-salt diet (Figure 8a).
Evolutionarily, natriuretic peptides were developed in
primitive vertebrates for their adaptation to survive. In
salmon and eels, e.g., natriuretic peptides are critical for
maintaining electrolyte homeostasis when these animals
migrate from fresh water to salty water during their life
cycle.36,37 Here we show that corin deficiency prevents mice
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from adapting to dietary salt challenges, indicating that this
ancient molecular mechanism is preserved in mammals for
similar purposes. Together, our data provide new insights
into the role of corin in regulating sodium homeostasis and
the mechanisms underlying salt-sensitive hypertension in
Cor/ mice. Genetic variants that impair corin function
have been identified in African Americans, a population
known for high prevalence of salt-sensitive hypertension.38
Our results suggest that corin defects may represent an
important mechanism underlying hypertension in humans.
MATERIALS AND METHODS
Mice
Cor/ mice were generated by deleting the exons coding for corin
active sites.16,39 Male Cor/ mice and WT littermates, aged 8–12
weeks old and weighing 20–30 g, were used in this study. Mouse
genotypes were not blinded to the persons who performed the
experiments. The mice were maintained in a facility with a 12-h
light–dark cycle and unrestricted access to food and water. The study
was conducted in accordance with the NIH guidelines for the ethical
treatment and handling of animals in research, and approved by the
Institutional Animal Care and Use Committee at the Cleveland Clinic.
Blood pressure measurements
Radiotelemetry was used to monitor blood pressure in conscious
and unrestrained mice.16 Mice were anesthetized with ketamine/
xylazine on a 37-1C warming plate. A TA11PA-C10 telemetry device
(Data Science International, St Paul, MN) was inserted into the left
common carotid artery under a microscope. After surgery, mice
were singly caged and fed with standard diet and water ad libitum.
Telemetry receivers (model RPC-1) were used for data acquisition
using the Dataquest System (Data Science International). After B7
days of postoperational recovery, blood pressure was recorded.
Effect of dietary salt on blood pressure
Mice were fed with diets containing normal (0.3% NaCl),
medium–high (2% NaCl), or high (4% NaCl) salts (Harlan Teklad,
Madison, WI) for 3 weeks. Blood pressure was monitored before,
during, and after the treatment of different salt diets.
Metabolic studies
Mice were placed singly in metabolic cages (Nalgene Labware, Lima,
OH) for a 5-day habituation period, during which a normal-salt diet
was fed. Next, mice were fed with the normal-salt diet for 3 days,
and then switched to a high-salt diet. Body weight, food
consumption, and water intake were measured daily. Urine samples
were collected in a device covered with water-saturated oil to
prevent sample evaporation. Urine volume in a 24-h period was
recorded. At different time points, mice were killed by CO2
inhalation and blood samples were collected in tubes (BD, Franklin
Lakes, NJ) containing heparin for electrolyte analysis or ethylene-
diaminetetraacetic acid for plasma renin concentration assay.
Plasma and urinary electrolytes
Plasma and urine samples were analyzed for sodium, potassium, and
chloride concentrations using an electrolyte analyzer (Roche
AVL9180, Indianapolis, IN).
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Figure 8 |Amlodipine normalized blood pressure in corin knockout (Cor/) mice on 0.3% but not 4% salt diets. Wild-type (WT)
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Effects of sodium or calcium channel blockers or Ang II
receptor antagonist
Mice on 0.3 or 4% NaCl diets were treated with amiloride (Alexis
Biochemicals, San Diego, CA), an ENaC blocker, or amlodipine
(Sigma, St Louis, MO), a calcium channel blocker, or losartan (US
Pharmacopeia, Rockville, MD), an Ang II receptor type 1 antagonist,
by intraperitoneal injection. The injection volume wasB0.1 ml, and
vehicles were used as controls. Blood pressure was monitored by
radiotelemetry, starting 7, 5, and 3 days after amiloride, amlodipine,
and losartan treatment, respectively. Urinary sodium excretion and
body weight change after drug treatment were measured.
Plasma renin and serum aldosterone assays
Active renin concentration in plasma was measured as the amount of
Ang I generated from angiotensinogen.40 Plasma samples were
diluted and incubated with excess porcine angiotensinogen (1mmol/
l, Sigma) in a reaction mixture containing sodium acetate (50 mmol/
l, pH 6.5), aminoethylbenzene sulfonyl fluoride (2.5 mmol/l), 8-
hydroxyquinoline (1 mmol/l), leupeptin (100mmol/l), and EDTA
(1 mmol/l) at 37 1C for 30 min. The reaction was stopped by heating
at 100 1C. Generated Ang I was determined by an enzyme
immunoassay (Peninsula Labs, San Carlos, CA). Plasma renin
concentration was expressed as the amount of Ang I generated per
microliter of plasma per hour. As a negative control, the reaction was
performed in the presence of pepstatin A (1mmol/l, Sigma). The
value from this reaction was used as a background. Serum
aldosterone levels were measured using an ELISA kit from Alpha
Diagnostic International (San Antonio, TX), according to the
manufacturer’s instructions.
Statistical analysis
Data were analyzed using the Prism software (Graph-Pad, La Jolla,
CA). Comparisons between two groups were made using Student’s
t-test. Three or more groups were compared using two-way analysis
of variance followed by post hoc least significant difference. All data
are presented as means±s.d. A P-value of o0.05 was considered to
be statistically significant.
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